Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Med. infant ; 31(1): 31-36, Marzo 2024. Ilus, Tab
Article in Spanish | LILACS, UNISALUD, BINACIS | ID: biblio-1552833

ABSTRACT

Introducción: Se ha postulado que el uso de vasopresina tendría efectos beneficiosos en el postoperatorio de cirugía cardiovascular. Objetivo: Evaluar la respuesta a la vasopresina en el postoperatorio (POP) de cirugía de Fontan de nuestra población. Métodos: Estudio de casos y controles anidados en una cohorte retrospectiva. Se incluyeron pacientes con cirugía de Fontan entre 2014 y 2019. Se registraron variables demográficas, datos del cateterismo pre-Fontan, días de asistencia respiratoria mecánica (ARM), necesidad de inotrópicos, diuréticos, diálisis, dieta hipograsa, octreotide, sildenafil y nutrición parenteral total (NPT); balance de fluidos al primer y segundo día POP, necesidad de cateterismo en el POP, días de permanencia de tubo pleural, días de internación, necesidad de reinternación y mortalidad. Se compararon los grupos con y sin vasopresina utilizando la prueba de Mann- Whitney-Wilcoxon test. Se consideró significativa una p < 0.05. Resultados: Del total analizado, 35 pacientes recibieron vasopresina. En el grupo control fueron 58 pacientes con características similares de gravedad sin vasopresina. No se encontraron diferencias en la evolución postoperatoria entre ambos grupos. El grupo con vasopresina recibió en mayor proporción dieta hipograsa. Conclusiones: En nuestra serie el uso de vasopresina no marcó diferencias significativas en términos de morbimortalidad con relación al grupo control (AU)


Introduction: The use of vasopressin has been suggested to have beneficial effects in the postoperative period after cardiovascular surgery. Objective: To evaluate the response to vasopressin in the postoperative period (POP) of Fontan surgery in our population. Methods: Nested case-control study in a retrospective cohort. Patients who underwent Fontan surgery between 2014 and 2019 were included. Demographic variables, pre-Fontan catheterization data, days of mechanical ventilation (MRA), need for inotropics, diuretics, dialysis, low-fat diet, octreotide, sildenafil and total parenteral nutrition (TPN); fluid balance at first and second day POP, need for catheterization at POP, duration of chest tube drainage, days of hospitalization, need for readmission, and mortality were recorded. Groups with and without vasopressin were compared using the Mann-Whitney- Wilcoxon test. A p < 0.05 was considered significant. Results: Of all patients analyzed, 35 received vasopressin. The control group consisted of 58 patients with similar severity characteristics who did not receive vasopressin. No differences were found in the postoperative outcome between the two groups. The vasopressin group received a higher proportion of low-fat diet. Conclusions: In our series the use of vasopressin did not show significant differences in terms of morbidity and mortality compared to the control group (AU)


Subject(s)
Humans , Infant , Child, Preschool , Postoperative Complications/drug therapy , Arginine Vasopressin/administration & dosage , Arginine Vasopressin/therapeutic use , Fontan Procedure/adverse effects , Antidiuretic Agents/administration & dosage , Antidiuretic Agents/therapeutic use , Indicators of Morbidity and Mortality , Retrospective Studies , Treatment Outcome , Hemodynamics
2.
Med. infant ; 20(3): 229-233, Sept.2013. tab
Article in Spanish | LILACS | ID: biblio-964272

ABSTRACT

Objetivo: evaluar eficacia del apósito impregnado con clorhexidina para reducir la colonización y la infección asociada a catéter (IAC). Pacientes y métodos: ensayo clínico, aleatorizado, controlado. Cohorte de 77 catéteres en pacientes posquirúrgicos cardiovasculares menores de 1 año y/o 10 kg. Grupo experimental: apósito con Clorhexidina, con curación transparente. Grupo control: apósito transparente. Se compararon características de los pacientes y de los catéteres. Resultados: Los pacientes y la permanencia del catéter fueron similares en ambos grupos. La tasa cruda de IAC fue 5,2% en el grupo control y en el experimental 0% (p= 0,14). Tasa de colonización 15% en el control y 7% en el experimental (p=0,26). El recambio de curaciones fue mayor en el grupo control (1,3 recambios) vs. grupo experimental 0,7 (p= 0,009). Conclusiones: El grupo experimental mostró menor índice de colonización, aunque sin significación estadística Los cambios de curación fueron menores en este grupo (AU)


Objective: To evaluate the efficacy of chlorhexidine-impregnated dressings to reduce colonization and catheter-related infection (CRI). Patients and methods: A randomized, controlled clinical trial was conducted. A cohort of 77 catheters in post-cardiovascular surgical patients younger than 1 year and/or weighing less than 10 kg was assessed. Experimental group: Chlorhexidine-impregnated transparent dressings. Control group: Transparent dressings. Patient and catheter features were compared. Results: Patients and mean catheter insertion duration were similar in both groups. CRI rate was 5.2% in the control group and 0% in the experimental group (p= 0.14). Colonization rate was 15% in the control and 7% in the experimental group (p=0.26). Dressing change was more frequent in the control group: 1.3 changes vs. 0.7 in the experimental group (p= 0.009). Conclusions: Colonization rate was lower in the experimental group, although no statistical significance was found. Dressing changes were less frequent in this group (AU)


Subject(s)
Humans , Infant, Newborn , Infant , Bandages , Catheterization, Central Venous/adverse effects , Chlorhexidine/administration & dosage , Chlorhexidine/therapeutic use , Catheter-Related Infections/prevention & control , Efficacy , Bacteremia/prevention & control , Heart Defects, Congenital/surgery , Anti-Infective Agents, Local/administration & dosage
SELECTION OF CITATIONS
SEARCH DETAIL